Final Results of a Phase II Trial of Clofarabine and Low-Dose Cytarabine Alternating with Decitabine in Older Patients with Newly Diagnosed Acute Myeloid Leukemia

Documenti analoghi

• Clofarabine plus Low-Dose Cytarabine Followed by Clofarabine plus Low-Dose Cytarabine Alternating with Decitabine in AML Frontline Therapy of Older Patients
  di: Faderl, Stefan, et al.
  Pubblicazione: (2012)
• Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients ≤60 Years with Newly Diagnosed Acute Myeloid Leukemia (AML)
  di: Nazha, Aziz, et al.
  Pubblicazione: (2013)
• Clofarabine plus low-dose cytarabine is as effective as and less toxic than intensive chemotherapy in elderly AML patients
  di: Takahashi, Koichi, et al.
  Pubblicazione: (2015)
• A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
  di: Faderl, Stefan, et al.
  Pubblicazione: (2008)
• Clofarabine Combinations as Acute Myeloid Leukemia Salvage Therapy
  di: Faderl, Stefan, et al.
  Pubblicazione: (2008)